Research supports potential effectiveness of blocking a pathway in pancreatic ductal adenocarcinoma.

Funds raised advance care, education, and research in orthopedics, rheumatology, and rehabilitation.

A new drug is effective in treating a rare kidney disease that has no FDA-approved therapies.

Patients 12 and older can receive diagnosis and treatment for minor conditions from their homes.

A new type of molecule blocks genes that drive the growth of therapy-resistant prostate cancer.

Dr. Mark Mulligan joins as director of NYU Langone’s Division of Infectious Diseases and Immunology.

Lay health workers used motivational interviewing to help participants alter lifestyle behaviors.

October is Breast Cancer Awareness Month—and the perfect time to get screened.